DOI: 10.1055/s-00000017

Experimental and Clinical Endocrinology & Diabetes

Issue 02 · Volume 112 · February 2004 DOI: 10.1055/s-002-3216

Editorial

73
Schatz, H.: Bringing Diabetologists from East and Central Europe Closer Together: New Tasks for the FID

Review

75
Temelkova-Kurktschiev, T.; Hanefeld, M.: The Lipid Triad in Type 2 Diabetes - Prevalence and Relevance of Hypertriglyceridaemia/Low High-Density Lipoprotein Syndrome in Type 2 Diabetes

Article

80
De Block, C. E. M.; De Leeuw, I. H.; Maassen, J. A.; Ballaux, D.; Martin, J.-J.: A Novel 7301-bp Deletion in Mitochondrial DNA in a Patient with Kearns-Sayre Syndrome, Diabetes Mellitus, and Primary Amenorrhoea
84
Fehmann, H.-C.; Groß, U.; Epe, M.: A New Mutation in the Hepatocyte Nuclear Factor-1-Alpha Gene (P224S) in a Newly Discovered German Family with Maturity-Onset Diabetes of the Young 3 (MODY 3). Family Members Carry Additionally the Homozygous I27L Amino Acid Polymorphism in the HNF1 Alpha Gene
88
Steines, W.; Piehlmeier, W.; Schenkirsch, G.; Renner, R.; Landgraf, R.: Effectiveness of a Disease Management Programme for Patients with Type 2 Diabetes Mellitus and Albuminuria in Primary Care - the PROSIT® Project (Proteinuria Screening and Intervention)
95
Bayer, Y.; Fasshauer, M.; Paschke, R.: The Novel Missense Mutation Methionine 442 Threonine in the Thyroid Hormone Receptor β causes Thyroid Hormone Resistance: A Case Report
98
Wolf, A.; Goretzki, P. E.; Röhrborn, A.; Feldkamp, J.; Simon, D.; Scherbaum, W. A.; Röher, H.-D.: Pheochromocytoma during Pregnancy: Laparoscopic and Conventional Surgical Treatment of Two Cases
102
Luboshitzky, R.; Herer, P.; Shen-Orr, Z.: Urinary 6-Sulfatoxymelatonin Excretion in Hyperandrogenic Women: The Effect of Cyproterone Acetate-Ethinyl Estradiol Treatment
108
Makarevich, A. V.; Sirotkin, A. V.; Franek, J.; Kwon, H. B.; Bulla, J.: The Role of Oxytocin, Protein Kinase A, and ERK-Related MAP-Kinase in the Control of Porcine Ovarian Follicle Functions

Short Communication

115
Göke, B.; Lübben, G.; Bates, P. C.; on behalf of the German Pioglitazone Study Group: Coefficient of β-Cell Failure in Patients with Type 2 Diabetes Treated with Pioglitazone or Acarbose